Leflunomide in Combination Therapy for Rheumatoid Arthritis

ISSN： 0114-5916

Source： Drug Safety, Vol.33, Iss.6, 2010-06, pp. : 523-526

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Leflunomide for the treatment of rheumatoid arthritis

By Miceli-Richard Corinne Dougados Maxime

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 6, 2003-06 ,pp. : 987-997

Informa Healthcare

Access to resources Recommend Favorite

Safety evaluation of leflunomide in rheumatoid arthritis

By I Keen Helen

Expert Opinion on Drug Safety, Vol. 12, Iss. 4, 2013-07 ,pp. : 581-588

Informa Healthcare

Access to resources Recommend Favorite

Modelling Cost Effectiveness and Cost Utility of Sequential DMARD Therapy Including Leflunomide for Rheumatoid Arthritis in Germany: II. The Contribution of Leflunomide to Efficiency

By Schädlich Peter K.

PharmacoEconomics, Vol. 23, Iss. 4, 2005-01 ,pp. : 395-420

Adis International

Access to resources Recommend Favorite

Leflunomide: a novel DMARD for the treatment of rheumatoid arthritis

By Alldred A. Emery P.

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 1, 2001-01 ,pp. : 125-137

Informa Healthcare

Access to resources Recommend Favorite

Leflunomide: A Review of its Use in Active Rheumatoid Arthritis

By Prakash A. Jarvis B.

Drugs, Vol. 58, Iss. 6, 1999-12 ,pp. : 1137-1164

Adis International

Access to resources Recommend Favorite